| Predicate |
Object |
| contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
| endingPage |
106 |
| issn |
1177-8881 |
| pageRange |
81-106 |
| publicationName |
Drug Design, Development and Therapy |
| startingPage |
81 |
| bibliographicCitation |
Deegan PB, Cox TM. Imiglucerase in the treatment of Gaucher disease: a history and perspective. Drug Des Devel Ther. 2012;6():81–106. PMID: 22563238; PMCID: PMC3340106. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a87df2479ab11b89649525fe144cd7b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e36178e5704a626da19a5b8941b87380 |
| date |
201204 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3340106
https://doi.org/10.2147/dddt.s14395
https://pubmed.ncbi.nlm.nih.gov/22563238 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36020
https://portal.issn.org/resource/ISSN/1177-8881 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Imiglucerase in the treatment of Gaucher disease: a history and perspective |
| discusses |
http://id.nlm.nih.gov/mesh/M0009360
http://id.nlm.nih.gov/mesh/M0239290 |